TOPLINE: Treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs), including liraglutide or semaglutide, for 12 months enabled patients to lose nearly all the weight they had regained after bariatric surgery. METHODOLOGY: Researchers conducted a single-centre retrospective study to examine the efficacy and safety of 12 months of treatment with GLP-1 RAs in patients who ...
.png)
Market Touch Signal · Finland · international digital desk
+358 400 512311
info@market-touch.org
